Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lachmann

Showing results (231-240 of 426) with videos related to

Pageof 43
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 10, 2004
Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish familiesElizabeth B Haagsma, Philip N Hawkins, Merrill D Benson, et al.
Blood|September 23, 2006
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosisAshutosh D Wechalekar, Hugh J B Goodman, Helen J Lachmann, et al.
European Journal of Neurology|March 3, 2016
Neurology of the cryopyrin-associated periodic fever syndromeT Parker, S Keddie, D Kidd, et al.
Immunology|September 1, 1990
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayersS Meri, B P Morgan, A Davies, et al.
Cancer Research|July 1, 1984
Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducersP S Sunkara, N J Prakash, A L Rosenberger, et al.
Pediatric Rheumatology Online Journal|July 10, 2019
Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndromeAbdulkadir A Elmi, Karen Wynne, Iek L Cheng, et al.
The Biochemical Journal|July 15, 1988
Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutationK S Aulak, P A Pemberton, F S Rosen, et al.
The Journal of Clinical Investigation|April 1, 1995
Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6R Würzner, M J Hobart, B A Fernie, et al.
Immunology|January 1, 1992
Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiencyA Orren, R Würzner, P C Potter, et al.
Blood|August 19, 2008
AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcomeAshutosh D Wechalekar, Helen J Lachmann, Hugh J B Goodman, et al.
Pageof 43

Showing results (231-240 of 426) with videos related to

Sort By:
Pageof 43
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 10, 2004
Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish familiesElizabeth B Haagsma, Philip N Hawkins, Merrill D Benson, et al.
Blood|September 23, 2006
Safety and efficacy of risk-adapted cyclophosphamide, thalidomide, and dexamethasone in systemic AL amyloidosisAshutosh D Wechalekar, Hugh J B Goodman, Helen J Lachmann, et al.
European Journal of Neurology|March 3, 2016
Neurology of the cryopyrin-associated periodic fever syndromeT Parker, S Keddie, D Kidd, et al.
Immunology|September 1, 1990
Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayersS Meri, B P Morgan, A Davies, et al.
Cancer Research|July 1, 1984
Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducersP S Sunkara, N J Prakash, A L Rosenberger, et al.
Pediatric Rheumatology Online Journal|July 10, 2019
Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndromeAbdulkadir A Elmi, Karen Wynne, Iek L Cheng, et al.
The Biochemical Journal|July 15, 1988
Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutationK S Aulak, P A Pemberton, F S Rosen, et al.
The Journal of Clinical Investigation|April 1, 1995
Molecular basis of subtotal complement C6 deficiency. A carboxy-terminally truncated but functionally active C6R Würzner, M J Hobart, B A Fernie, et al.
Immunology|January 1, 1992
Properties of a low molecular weight complement component C6 found in human subjects with subtotal C6 deficiencyA Orren, R Würzner, P C Potter, et al.
Blood|August 19, 2008
AL amyloidosis associated with IgM paraproteinemia: clinical profile and treatment outcomeAshutosh D Wechalekar, Helen J Lachmann, Hugh J B Goodman, et al.
Pageof 43